A microRNA signature of response to erlotinib is descriptive of TGFβ behaviour in NSCLC
Madeline Krentz Gober(University of Kentucky), Esther P. Black(University of Kentucky)
Cited by 7
Related Papers
A microRNA gene expression signature predicts response to erlotinib in epithelial cancer cell lines and targets EMT
|British Journal of Cancer|2011|78